secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2025-04-07T23:59:59+00:00
Accession:  0001641172-25-002862
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo shareholders approve authorized share increase to 75M, stock plan expansion, and removal of 10.1M-share lock-up
--------------------------------------------------------------------------------

- Authorized common stock increased from 50M to 75M shares; stock incentive plan pool raised by 2.5M to 6.15M shares.
- Voting and transfer restrictions on 10,101,010 shares held by 22NW Fund, LP removed per shareholder approval.
- Class I directors Joseph F. Lawler, Richard Anthony Cunningham, Aron R. English re-elected.
- Ratification of EisnerAmper LLP as independent auditor for fiscal 2025 approved.
- All proposals passed with strong majorities; record date had 41,084,731 shares outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000164117225002862/0001641172-25-002862-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000164117225002862/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-002862

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer